Automation News and Research

RSS

Scintica and Indus Instruments introduce PulSAR MD: An integrated M-Mode and Doppler data acquisition system with powerful automatic analysis

Scintica and Indus Instruments are proud to introduce PULSAR MD (Preclinical Ultrasound for Small Animal Research M-Mode and Doppler) system, the next evolution in preclinical hemodynamic assessment.

From Scintica Instrumentation Inc. 20 Aug 2026

Multi-source data-driven machine learning improves lung cancer care

Lung cancer remains one of the malignancies with the highest incidence and mortality worldwide.

17 Aug 2026

Choosing the right benchtop fluorescence microscope for your lab

Learn what matters when comparing benchtop fluorescence microscopes, from confocal and widefield imaging to software.

From Oxford Instruments - Life Sciences 17 Aug 2026

Automated MRI system improves improves evaluation of experimental stroke therapies

Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have developed an automated system that uses MRI to measure brain tissue changes in animal models for large, multicenter studies of experimental stroke treatments.

12 Aug 2026

Insilico Medicine nominates powerful oral drug candidate for the management of heart risks

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the nomination of ISM0900, a potent, AI-driven, highly selective, orally available small molecule inhibitor of lipoprotein(a), or Lp(a), as a preclinical candidate (PCC) for the management of cardiovascular risks.

12 Aug 2026

Bruker announces strategic collaboration with Atinary Technologies to advance Self-Driving Laboratories

Bruker Corporation today announced an expanded strategic collaboration with Atinary Technologies Inc., the pioneer of Self-Driving Labs® technologies and AI-driven R&D with applications in pharmaceuticals, chemicals, energy, and materials.

From SciY 12 Aug 2026

CN Bio awarded Innovate UK grant to reduce animal use in pharmacokinetic studies

CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced it has been awarded £180 k grant funding from Innovate UK.

From CN Bio 12 Aug 2026

SwRI researchers design better inhalers for young children

A Southwest Research Institute (SwRI) project is developing techniques to improve inhalers for young children and other people who can't inhale deeply.

11 Aug 2026

Leica Biosystems enables faster cancer diagnoses through multiple digital pathology FDA clearances, including industry-first AI-assisted quality control software

Leica Biosystems introduces AI-driven quality control in digital pathology, streamlining workflows and enhancing diagnostic accuracy for better patient care.

From Leica Biosystems 11 Aug 2026

Early-life stress rewires brain epigenetics to heighten sensitivity to future stress

. Early-life stress increased SETD7 and H3K4me1 in the ventral tegmental area of mice, creating an epigenetically primed state that heightened later transcriptional, neuronal, and behavioral responses to stress. Reducing Setd7 during development lowered H3K4me1 and weakened these stress-sensitizing effects, identifying a mechanism that may help explain how early adversity leaves lasting biological effects.

11 Aug 2026

What 38,000 trauma and incident records reveal about e-scooter safety

E-scooter riders admitted with moderate-to-severe trauma showed a distinct injury profile, with proportionally more traumatic brain, vascular, and internal organ injuries than motorcyclists and fewer fractures. Rental-scooter data also linked greater reported injury severity with younger age and female sex, while collision rates varied with area-level deprivation.

10 Aug 2026

Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a collaborative study in the journal npj Precision Oncology.

4 Aug 2026

New 3D brain tissue model accelerates Alzheimer's drug development

How can Alzheimer's research be made faster, better, and more effective? After decades of intensive research worldwide and despite recent therapeutic advances, scientists have not managed to fully arrest the progress of the disease.

4 Aug 2026

DNA Script and leading healthcare solutions provider awarded up to $26 M by ARPA-H to advance cell-free DNA bioproduction

DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced that in collaboration with prime awardee GE HealthCare, they have been awarded up to $26 million in funding for a four-year initiative from the Advanced Research Projects Agency for Health (ARPA-H).

From DNA Script 4 Aug 2026

Automated oxygen delivery system improves precision for hospitalized patients

A University of Colorado Anschutz-led clinical trial has found an automated oxygen delivery system helped hospitalized patients spend significantly more time in their target oxygen range compared with standard care, while also reducing exposure to both low and high oxygen levels.

3 Aug 2026

New analytical strategies can measure thousands of gut microbial proteins

The trillions of microorganisms living in our intestine influence our health, from digestion and metabolism to immunity.

3 Aug 2026

Insilico unveils standardized evaluation framework to validate AI-driven drug discovery models

As general-purpose and domain-specific AI models rapidly infiltrate drug discovery, one critical question looms over the pharmaceutical sector: Can these models actually discover drugs, or are they just good at taking tests?

30 Jul 2026

How real-time off-gas analysis improves fermentation process control

Real-time off-gas analysis helps optimize fermentation by improving process control, reducing failed batches and supporting faster development.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 29 Jul 2026

FDA grants fast track designation to Insilico's AI-designed mesothelioma drug candidate

Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that ISM6331, a novel, potential best-in-class pan-TEAD inhibitor driven by Insilico's proprietary AI, has received Fast Track Designation (FTD) from the U.S.

29 Jul 2026

New blood test could save millions through early tuberculosis detection

A new study presented today at ADLM 2026 in Anaheim, California found that a simple blood test could accurately identify tuberculosis (TB) - a leading cause of death worldwide - among patients with varying degrees of exposure to the disease.

28 Jul 2026